JANX – Janux Therapeutics Inc
Investors holding1
Combined shares23,307
Combined reported value$403K
JANX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.00 | Reduced 17.0% | 23,307 | $403K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 17.0% | 23,307 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 5.5% | 28,070 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 62.5% | 29,689 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 19.7% | 79,158 | 0.00 |
Added: opened or increased
No tracked investor opened or increased this position in the last 4 quarters.
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 17.0% | 23,307 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 5.5% | 28,070 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 62.5% | 29,689 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 19.7% | 79,158 | 0.00 |
History
1 peakQ3 2026: 1 tracked investors
20242026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 23.3K | 28.1K | 29.7K | 79.2K | 98.6K | 113.7K | 174.3K | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).